about

IPFA members

facts about

events and

All events

Event information:

Registration
Programme/proceedings
Corporate partners
Contact

IPFA/PEI 27th International Workshop on Surveillance and Screening of Blood-borne Pathogens – Virtual

Thank you for attending!

The first IPFA/PEI Virtual Workshop is a fact. We have welcomed 288 delegates from 39 countries these past 3 days. Thank you all for attending! We hope you have enjoyed the sessions and reached out to our sponsors.

Thank you to:
– Our Scientific Committee creating a high quality programme
– Our speakers and moderators, taking the time and effort in presenting and take part in the Q&A’s
– Our Sponsors, this workshop would not have been possible without our them. We are very grateful for their trust and support.
– The Technical Team from Key4Events, ensuring a smooth execution
– And you, the attendees, participating in our workshop!

The proceedings of all presentations are now available on this website.

While we hope to meet in-person again soon, we do hope you have enjoyed this Virtual experience.

Dr. Leni von Bonsdorff          Executive Director IPFA
Dr. Micha Nübling                  PEI

Organised and Supported by:

Event partner(s):

Abbott Diagnostics sponsor IPFA Events, the International Plasma and Fractionation Association
Roche, sponsor of IPFA Events, International Plasma and Fractionation Association
PCL Inc. Sponsor of the IPFA PEI Workshop on Surveillance and Screening of Blood-borne Pathogens
Grifols sponsor events IPFA, the International Plasma and Fractionation Association

Registration

The Workshop registration fee includes:

  • Access to the the Live programme and interactive discussions
  • Access to on-demand content from 7 May until 30 June, 2021
  • Access to content from our corporate sponsors
  • The opportunity to network with participants around the world

Participants will have access to the virtual congress platform from 4 May until 30 June, 2021 (23:59 CEST).

Scientific Programme

Registration fees:

  • Regular: € 150
  • Low/Middle Income countries: €100

Click here for the World Bank Index Category (High, Upper middle, Lower Middle or Low) to view the list of countries.

Corporate Partners

The IPFA/PEI workshop is recognized as the leading event for discussion and assessment of all types of risks caused by infectious agents which may have an impact of the safety of blood and plasma. The development, progress and implementation of techniques related to testing and processing of blood and plasma form an important part of the program. The Workshop now represents an identified body of expertise, which provides direction for emerging applications of these technologies and issues related to blood safety in general.

Event partner(s):

Abbott Diagnostics sponsor IPFA Events, the International Plasma and Fractionation Association
Roche, sponsor of IPFA Events, International Plasma and Fractionation Association
PCL Inc. Sponsor of the IPFA PEI Workshop on Surveillance and Screening of Blood-borne Pathogens
Grifols sponsor events IPFA, the International Plasma and Fractionation Association

Programme / Proceedings

Tuesday 4 May, 2021

Session 1 - 14:54 CET
Official Opening
  • Words of Welcome - Leni von Bonsdorff, Executive Director IPFA
Session 2 - 15:00-16:30 CET
THE SARS-Cov-2 PANDEMIC
In perhaps a departure from our usual focus the scientific programme committee felt that a meeting such as this would not be complete without consideration of the impact of the SARS-CoV-2 pandemic on the activities of the transfusion communities. This session will consider evidence for any risk of SARS-CoV-2 transmission by transfusion, followed by discussion of the principles and challenges for on going serosurveillance, consideration of the criteria for selection of antibody assays. The session will conclude with a review of what knowledge has been gained from blood donor serosurveillance studies and prospects for the future.
Brian Custer (United States), Françoise Rossi (France)
BREAK
16:30 - 16:45 CET
Session 3 - 16:45 -17:45 CET
PASSIVE IMMUNOTHERAPIES
This session focusses on the evolution and efficacy of passive immunization as a therapeutic option for treatment of SARS-CoV-2 including the emergence of neutralizing antibodies in donor plasma pools used for PDMP manufacture.
Pierre Tiberghien (France), Anneliese Hilger (Germany)
Session 4 - 17:45 - 18:15 CET
Pierre Tiberghien (France), Anneliese Hilger (Germany)
  • Q&A and Panel Discussion on SARS-Cov-2

Wednesday May 5, 2021

Session 5: 15:00 - 16:30 CET
THE HIV PANDEMIC
Here we will see a return to the more familiar territory of the other pandemic – HIV. We will consider challenges and progress towards an end to the HIV pandemic and progress prospects for a cure.
Michael Busch (United States), Hans Zaaijer (The Netherlands)
BREAK
16:30 - 16:45 CET
Session 6: 16:45 - 18:25 CET
HIV - IMPLICATIONS FOR TRANSFUSION
Session 6 will focus on topics of specific interest and relevance to transfusion and in particular implications for MSM donors – including donor selection and deferral policies and the impact and implications of ARV and PrEP use by blood donors.
Christian Erikstrup (Denmark), Guy Rautmann (France)

Thursday May 6, 2021

Session 7: 15:00 - 15:45 CET
BREAKING NEWS AND UPDATE
Two topics have been identified for inclusion in this year’s programme. The first of these entitled "Harmonising Calibration of Serological Assays for SARS-CoV-2” will be presented by Dr Neil Almond, NIBSC (United Kingdom). The second presentation in this session is by Dr Tony Fauci MD, NIH, United States entitled "Lessons from the Concurrent HIV/AIDS and COViD-19 Pandemics” - juxtaposing experiences and lessons to be learnt from these pandemics. This presentation was recently presented to the University of California San Francisco – Gladstone Center for AIDS Research (UCSF – Gladstone CFAR) and we are grateful for their and Dr Fauci’s kind permission to include this presentation in our meeting.
Both topics will be of interest and relevance in light of the HIV and SARS-Cov-2 focus for the meeting.
Heli Harvala (United Kingdom)
BREAK
15:45 - 16:00 CET
Session 8: 16:00 - 17:40 CET
MANUFACTURERS SESSION
The annual IPFA/PEI Workshop provides an opportunity for commercial organisations, which provide support and technologies for the blood and plasma industry, to present scientific and technical developments in their companies. This partnership between companies supplying state of the art processing and testing technologies and those responsible for safeguarding the supply of blood and plasma products has and will continue to be an important part of the workshop programme.
Bob Perry (United Kingdom)
Session 9: 17:40 - 19:00 CET
FUTURE PREPAREDNESS FOR PANDEMICS
In light of the global and ongoing impact of SARS-CoV-2 it is appropriate to conclude this year’s meeting with consideration and discussion of strategies to better prepare for future pandemics – in the context of both transfusion safety and the wider perspective of global public health. This session will therefore consider the potential role of novel and emerging molecular technologies for viral surveillance, the value of global immunological observatories and the potential contribution of blood donors as a sentinel population for global surveillance and monitoring.
Micha Nübling (PEI, Germany), Merlyn Sayers (United States)
  • 17:40 - 18:00: Novel Molecular Technologies for Viral Surveillance - C. Chiu, UCSF (United States)
  • 18:00 - 18:20: Global Immunological Observatory - M.J. Mina, Harvard Medical School (United States)
  • 18:20 - 18:40: Blood Donors as Sentinel Population - C. Erikstrup, Aarhus University (Denmark)
  • 18:40 - 19:00: Live and Interactive Q&A
CLOSING
19:00 CET
Scientific Programme

Contact

International Plasma and Fractionation Association (IPFA)

Mrs Sophie Sanders

T. +31 (0)20 – 512 3561
info@ipfa.nl